Evidence map›Paper›PMID 32514373›Full record

ArticleClinical hypertension2020

Hypertension prevalence and its trend in Bangladesh: evidence from a systematic review and meta-analysis.

Mohammad Ziaul Islam Chowdhury, Meshbahur Rahman, Tanjila Akter, Tania Akhter, Arifa Ahmed, Minhajul Arifin Shovon, Zaki Farhana, Nashit Chowdhury, Tanvir C Turin

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Clinical hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05155436 (Prevalence and Incidence of Dyskalemia in Hypertensive Patients Initiating a Fixed Dose Combination Pill of Telmisartan and Amlodipine), which is not on this map. Cited by 76 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 5 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05155436 phase4completednot on this mapstarted 2022, after this paper: background citation

Prevalence and Incidence of Dyskalemia in Hypertensive Patients Initiating a Fixed Dose Combination Pill of Telmisartan and Amlodipine

TypeinterventionalSponsorNational Heart Foundation of BangladeshRan2022 to 2023Enrolled1,090ConditionsHypertension, Potassium ImbalanceArmsFixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 5 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mohammad Ziaul Islam ChowdhuryDepartment of Community Health Sciences, University of Calgary, TRW Building (3rd Floor), 3280 Hospital Drive NW, Calgary, Alberta T2N 4Z6 Canada.
Meshbahur RahmanDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Tanjila AkterDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Tania AkhterDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Arifa AhmedDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Minhajul Arifin ShovonDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Zaki FarhanaDepartment of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Nashit ChowdhuryDepartment of Family Medicine, University of Calgary, Calgary, Alberta Canada.
Tanvir C TurinDepartment of Family Medicine, University of Calgary, Calgary, Alberta Canada.
Shahjalal University of Science and Technology · BDUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypertension, itself being a major chronic condition, is one of the most significant risk factors for premature cardiovascular diseases and mortality. Hypertension is responsible for 13% of global deaths and three-quarters of the world's hypertensive population reside in low- and middle-income countries. Bangladesh is one of those countries that experiencing an epidemiological transition from communicable to non-communicable diseases, a nutritional transition from a traditional diet to process and fast food, and an increase in a sedentary lifestyle, resulting in increased hypertension prevalence. We carried out a systematic review and meta-analysis to identify existing research on hypertension prevalence in Bangladesh, summarize findings and assess its temporal change.

methodsWe searched MEDLINE, EMBASE and PubMed and relevant references to identify studies on the prevalence of hypertension in Bangladesh. We used Random-effects meta-analysis to pool the prevalence estimates and performed subgroup analyses. We assessed heterogeneity, a trend in prevalence of hypertension and publication bias in selected studies.

resultsOur search initially identified 735 articles and after removing duplicates, reviewing titles and abstracts, and screening full texts, 53 studies were finally selected. The studies comprised 305,432 subjects and reported overall, gender-specific, geographical location specific and criteria specific prevalence of hypertension. We identified the range of hypertension prevalence is from 1.10% to 75.0% and the overall weighted pooled prevalence of hypertension is 20.0%. An extremely high heterogeneity (I

conclusionsThe prevalence of hypertension is high and rising in Bangladesh. Strategies targeting prevention are required to mitigate a further increase in the prevalence and reduce the morbidity and mortality associated with it.

Indexed as

BangladeshHypertensionPrevalenceTrend

Identifiers

PMID32514373
PMCPMC7262759
OpenAlexW3032840990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.